Trial Profile
Post-licensing experience with Perampanel in patients with partial-onset seizures
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Therapeutic Use
- 16 Dec 2015 New trial record